Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors (Q36407318)
scientific article
Language:
(P31) (Q13442814)
(P304) 307-315
(P407) (Q1860)
(P433) 3
(P478) 15
(P577) Wednesday, March 1, 2006
(P921) (Q12174)
(Q17907844)
(Q422936)
(Q421237)
(P1433) (Q5421208)
(P1476) "Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors" (language: en)
(P2093) Eli V Gelfand
Christopher P Cannon
(P2860) (Q34327135)
(Q27860959)
(Q47268558)
(Q30769299)
(Q34381705)
(Q44633865)
(Q44558091)
(Q28140155)
(Q34154695)
(Q24558751)
(Q28575514)
(Q31136248)
(Q35874165)
(Q28343769)
(Q44303656)
(Q45081681)
(Q44413150)
(Q37372676)
(Q43658822)
(Q43818881)
(Q28263081)
(Q35169067)
(Q24673420)
(Q42981075)
(Q28242954)
(Q46499076)
(Q43759232)
(Q44444449)
(Q34332716)
(Q42014580)
(Q35040754)
(Q24651338)
(Q36065409)
(Q44193713)
(Q46807918)
(Q44915184)
(P13046) (Q7318358)
other details
description scientific article

External Links